Repare Therapeutics Inc. (RPTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 3.1500 |
| Open | 3.1800 |
| Bid | 3.1500 x 400 |
| Ask | 3.2200 x 400 |
| Day's range | 3.1200 - 3.2280 |
| 52-week range | 2.9800 - 13.8500 |
| Volume | |
| Avg. volume | 132,080 |
| Market cap | 134.983M |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.2300 |
| Earnings date | 26 Feb 2024 - 01 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.33 |
- Business Wire
Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
CAMBRIDGE, Mass. & MONTREAL, April 26, 2024--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the Company’s upcoming annual meeting of shareholders in June 2024. The Company also announces that Todd Foley has decided not to stand for re-election as a director of the Company following the end of his current term a
Simply Wall St.Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms bore the brunt
Key Insights Significant control over Repare Therapeutics by private equity firms implies that the general public has...
Simply Wall St.Repare Therapeutics Full Year 2023 Earnings: Misses Expectations
Repare Therapeutics ( NASDAQ:RPTX ) Full Year 2023 Results Key Financial Results Revenue: US$51.1m (down 61% from FY...
© 2024 Yahoo. All rights reserved.